226 related articles for article (PubMed ID: 32553611)
1. Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets.
Mahler M; Hudson M; Bentow C; Roup F; Beretta L; Pilar Simeón C; Guillén-Del-Castillo A; Casas S; Fritzler MJ
Autoimmun Rev; 2020 Aug; 19(8):102583. PubMed ID: 32553611
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance.
Cepeda EJ; Reveille JD
Curr Opin Rheumatol; 2004 Nov; 16(6):723-32. PubMed ID: 15577611
[TBL] [Abstract][Full Text] [Related]
4. Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis.
Cabral-Marques O; Riemekasten G
Autoimmun Rev; 2016 Jul; 15(7):690-4. PubMed ID: 26970493
[TBL] [Abstract][Full Text] [Related]
5. Early inflammatory players in cutanous fibrosis.
Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
[TBL] [Abstract][Full Text] [Related]
6. Role of Alarmins in the Pathogenesis of Systemic Sclerosis.
Giovannetti A; Straface E; Rosato E; Casciaro M; Pioggia G; Gangemi S
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679721
[TBL] [Abstract][Full Text] [Related]
7. [Systemic sclerosis: different subsets and disease remitting drugs].
Ogawa T; Saito E
Nihon Rinsho; 1999 Feb; 57(2):344-8. PubMed ID: 10078002
[TBL] [Abstract][Full Text] [Related]
8. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune Skin Conditions: Systemic Sclerosis.
Helm LA; Clebak KT; Foulke G; Helm M
FP Essent; 2023 Mar; 526():18-24. PubMed ID: 36913659
[TBL] [Abstract][Full Text] [Related]
10. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
Yoshizaki A
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
[TBL] [Abstract][Full Text] [Related]
12. Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status.
Kane GC; Varga J; Conant EF; Spirn PW; Jimenez S; Fish JE
Respir Med; 1996 Apr; 90(4):223-30. PubMed ID: 8736656
[TBL] [Abstract][Full Text] [Related]
13. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
Coelho Horimoto AM; da Costa IP
Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic autoantibodies in systemic sclerosis.
Gabrielli A; Svegliati S; Moroncini G; Avvedimento EV
Curr Opin Immunol; 2007 Dec; 19(6):640-5. PubMed ID: 18083509
[TBL] [Abstract][Full Text] [Related]
15. Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early/early SSc or pre-SSc).
Valentini G
Autoimmun Rev; 2015 Mar; 14(3):210-3. PubMed ID: 25461837
[TBL] [Abstract][Full Text] [Related]
16. Genetic factors and systemic sclerosis.
Murdaca G; Contatore M; Gulli R; Mandich P; Puppo F
Autoimmun Rev; 2016 May; 15(5):427-32. PubMed ID: 26826434
[TBL] [Abstract][Full Text] [Related]
17. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic profiles for precision medicine in systemic sclerosis; stepping forward from single biomarkers towards pathophysiological panels.
Smeets RL; Kersten BE; Joosten I; Kaffa C; Alkema W; Koenen HJPM; Vonk MC
Autoimmun Rev; 2020 May; 19(5):102515. PubMed ID: 32173517
[TBL] [Abstract][Full Text] [Related]
19. Systemic sclerosis.
Asano Y
J Dermatol; 2018 Feb; 45(2):128-138. PubMed ID: 29226387
[TBL] [Abstract][Full Text] [Related]
20. Immunology of systemic sclerosis.
Artlett CM
Front Biosci; 2005 May; 10():1707-19. PubMed ID: 15769660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
